ArticleFrontiers in immunology2021

Preclinical Immune Response and Safety Evaluation of the Protein Subunit Vaccine Nanocovax for COVID-19.

Thi Nhu Mai Tran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.